CD8A and cutaneous leishmaniasis: In mice vaccinated with NH36, protection against VL is mediated by a CD4+ T cell response to the NH36 C-terminal domain (F3), and against cutaneous leishmaniasis (CL), by a CD4+ response against F3 and a CD8+ response against the NH36 N-terminal (F1).